AzTrials
AzTrials

Sleep DisorderNCT03326765

Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)

A study testing Questionnaires, electroencephalogram (EEG) and polysomnography in people with Sleep Disorder, run by Universitair Ziekenhuis Brussel at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The proposed research project is aimed at further characterization of sleep problems and evaluation of their impact in children and adults with TSC, excluding epilepsy as contributing factor. Read more about this study

Who is it for?
Ages 1 day to 70 yearsHealthy volunteers can take part
Conditions the study is for
Sleep Disorder
What is being tested?
Questionnaires, electroencephalogram (EEG) and polysomnography
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteBelgium
Study dates
27 Sep 2017to 30 Nov 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Children and adults with definite TSC based on the 2012 Consensus Conference Diagnostic

Who cannot join

  • daily alcohol intake
  • pregnancy
  • caffeine abuse (>4 cups/day)
  • shift work
  • drug abuse
  • anti-depressive therapy
  • medications as benzodiazepine, melatonin, phenobarbital and antihistamines
  • the presence of clinical or electrographic seizures.

Trial locations and contacts

1 site in 1 country.

Veerle Van Mossevelde, Study coordinator contact

+3224763134

veerle.vanmossevelde@uzbrussel.be

Dirk De Clippeleir, Study coordinator contact

+3224763580

dirk.declippeleir@uzbrussel.be

Belgium1 site, 1 recruiting
  • Universitair Ziekenhuis Brussel

    Jette, Vlaams Brabant, 1090

    Veerle Van Mossevelde, Datanurse, +3224763134, veerle.vanmossevelde@uzbrussel.be

    Recruiting

Other trials in Belgium

About this study

The proposed research project is aimed at further characterization of sleep problems and evaluation of their impact in children and adults with TSC, excluding epilepsy as contributing factor. Questionnaire-based studies have shown that sleep problems occur in up to half of the children and a third of adults with tuberous sclerosis complex (TSC). However, there is only limited information on the nature of sleep problems and their impact on patients with TSC and their families.

Read the detailed description

Questionnaire-based studies have shown that sleep problems occur in up to half of the children and a third of adults with tuberous sclerosis complex (TSC). However, there is only limited information on the nature of sleep problems and their impact on patients with TSC and their families. It is known from a questionnaire-based study in children with TSC that they often wake early or wake frequently during the night, and that they can be more tired during the day. In some children, sleep-problems seem to be related to the presence of seizures during the night. This has been confirmed in a study on 10 children with TSC and epilepsy by a combination of polysomnography (sleep study) and electroencephalography (EEG). A questionnaire-based study in adults also revealed the association with epilepsy features, and showed influence of mental health complaints on sleep.

Sleep structure and quality will be assessed through formal sleep studies (polysomnography and actigraphy). The influence of abnormal brain activity on sleep will be mapped by simultaneous recording of brain activity by means of EEG. The impact of sleep disorders will be determined through interviews with individuals with TSC and their relatives. The investigators will also use questionnaires and diaries to supplement their findings.

Importance: It is expected that the results of this study will 1) improve our understanding of sleep problems in TSC, 2) provide additional information on the influence of TSC on sleep, 3) give a more in-depth view on the impact of sleep problems on the lives of individuals with TSC and their families, 4) increase awareness about sleep problems in TSC, and 5) contribute to a better management of sleep problems by patients and families.

Conditions
Sleep Disorder
Being tested
Questionnaires, electroencephalogram (EEG), polysomnography, Actigraphy
Keywords
tuberous sclerosis complex (TSC), Children, Adults
Medical subject headings
Sleep Wake Disorders, Tuberous Sclerosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnairesOther

    • Epworth sleepiness scale
    • Pittsburgh sleep quality Index (PSQI)
    • EQ-5D Adults
    • Pediatric Daytime Sleepiness scale (PDSS)
    • Sleep disturbance Scale for Children (SDSC
    • EQ-5D Children
    • Sleaping diary
  • electroencephalogram (EEG)Procedure or surgery

    is an electrophysiological monitoring method to record electrical activity of the brain

  • polysomnographyProcedure or surgery

    type of sleep study, is a multi-parametric test used in the study of sleep and as a diagnostic tool in sleep medicine

  • ActigraphyProcedure or surgery

    type of sleep study based on bracelet around the wrist

Study groups in NCT03326765
Study groupRoleWhat they receive
ChildrenOtherQuestionnaires electroencephalogram (EEG) Actigraphy polysomnography
Receives: Other: Questionnaires; Procedure: electroencephalogram (EEG); Procedure: polysomnography; Procedure: Actigraphy
AdultsOtherQuestionnaires electroencephalogram (EEG) Actigraphy polysomnography
Receives: Other: Questionnaires; Procedure: electroencephalogram (EEG); Procedure: polysomnography; Procedure: Actigraphy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. characterize the sleep phenotype of TSC in children and adults without epilepsy

    • Sleep efficiency (SE%): the percentage ratio between total sleep time and time in bed (TST/TIB*100)

    Measured: 1 night

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Oct 2017
  2. Study start27 Sep 2017
  3. Primary completion1 Nov 2019 (estimated)
  4. Study completion30 Nov 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
2 groups: * 30 Children(0-18y) withTSC without epilepsy * 30 Adults(\>18y) withTSC without epilepsy
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03326765
Sponsor's protocol ID
TSC v 1.0
Status last verified
Oct 2018
First submitted
6 Oct 2017
Last updated
17 Oct 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Questionnaires, electroencephalogram (EEG) and polysomnography in people with Sleep Disorder, run by Universitair Ziekenhuis Brussel at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Veerle Van Mossevelde, Study coordinator (+3224763134, veerle.vanmossevelde@uzbrussel.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

characterize the sleep phenotype of TSC in children and adults without epilepsy (time frame: 1 night). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Oct 2018; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in